Billy Goat Announces Grant of Restricted Share Units and Option

Billy Goat Brands Ltd. (the "Company" or "Billy Goat") (CSE: GOAT), is pleased to announce that it has granted an aggregate of 11,500,000 restricted share units ("RSUs") to certain arm's-length consultants, and an aggregate of 1,000,000 incentive stock options ("Options") to directors of the Company to purchase up to 1,000,000 common shares of the Company at a price of $0.05 per common share for a period of five years from grant, as compensation for continuing services rendered to the Company.

The RSUs and the Options will vest four months and one day from the date of issuance, subject to earlier vesting in the event of a change of control and subject to the policies of the Canadian Securities Exchange.

Upon vesting, each RSU entitles the holder to receive one common share of the Company in exchange.

ABOUT BILLY GOAT BRANDS

Billy Goat Brands is an investment issuer focused on investing in high-potential companies operating in the plant-based food technology sector. It intends to accomplish these goals through the identification of and investment in securities of private listed entities that are involved in the food and beverage industry, with a focus on: (i) plant-based protein, (ii) functional foods, (iii) food technology, (iv) fermented foods, and (v) cultured and cell agriculture. The Company plans to generate returns on its investments through various outcomes, including but not limited to go-public transactions, mergers or acquisitions, and the other liquidity events of its investee companies or projects. The paramount goal of the Company will be to generate maximum returns from its investments in a manner consistent with its environmental, social and governance values. For more information about the Company, please visit https://billygoatbrands.com/.

The Company's final prospectus, financial statements and management's discussion and analysis, among other documents, are all available on its profile page on SEDAR at www.sedar.com. The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY STATEMENT REGARDING "FORWARD-LOOKING" INFORMATION

This news release contains certain forward-looking statements within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. The Company has provided the forward-looking statements in reliance on assumptions that it believes are reasonable at this time. All such forward-looking statements involve substantial known and unknown risks and uncertainties (including those risk factors identified in the Company's prospectus dated February 15, 2022), certain of which are beyond the Company's control. Such risks and uncertainties include, without limitation, delays resulting from or inability to obtain required regulatory approval. The reader is cautioned that the assumptions used in the preparation of the forward-looking statements may prove to be incorrect and the actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what benefits, including the amount of proceeds, the Company will derive therefrom. Readers are cautioned that the foregoing list of factors is not exhaustive. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

CONTACT INFORMATION

Billy Goat Brands Ltd.

Investor Relations

Email: info@billygoatbrands.com

Phone: 604-687-2038

Source

Click here to connect with Billy Goat Brands Ltd. (CSE: GOAT), to receive an Investor Presentation